CRNX · CIK 0001658247 · operating
Crinetics Pharmaceuticals, Inc. (CRNX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $4.2 billion, Crinetics Pharmaceuticals, Inc. is a mid-cap company. The stock currently trades at $40.68, down 1.02% today, with a 52-week range of $24.10–$57.99.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-4.95 | $-4.95 | -34.1% | |
| 2024 | $-3.69 | $-3.69 | +0.0% | |
| 2023 | $-3.69 | $-3.69 | -17.1% | |
| 2022 | $-3.15 | $-3.15 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001658247-26-000012 | SEC ↗ |
| 2024-12-31 | 2025-02-27 | 0000950170-25-029050 | SEC ↗ |
| 2023-12-31 | 2024-02-28 | 0000950170-24-022108 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0000950170-23-005132 | SEC ↗ |
| 2021-12-31 | 2022-03-30 | 0000950170-22-005050 | SEC ↗ |
| 2020-12-31 | 2021-03-30 | 0001564590-21-016719 | SEC ↗ |
| 2019-12-31 | 2020-03-09 | 0001564590-20-009365 | SEC ↗ |
| 2018-12-31 | 2019-03-13 | 0001564590-19-007561 | SEC ↗ |